myco_lab_laboratory_methods_in_the_diagnosis_of_viral_diseases

Definition: Techniques for detecting viruses via cytologic (cell) or histologic (tissue) examination for characteristic viral inclusions.
Viral Inclusions: Intracellular structures formed by aggregates of viruses or components within infected cells; also includes abnormal cellular materials from virus-induced metabolic disruptions.
- Inclusions can occur in single or syncytial cells (fused cells).
Techniques:
- Pap and Giemsa-stained cytologic smears are used to detect inclusions or syncytia.
- Viral inclusions observed include those caused by CMV, adenovirus, parvovirus, papillomavirus, and molluscum contagiosum virus, often through hematoxylin and eosin or Pap staining.
- Less common inclusions from measles and rabies (Negri bodies in brain tissue) can also be detected.
Sensitivity:
- Less sensitive than culture methods but very useful for viruses that are difficult to isolate, like parvovirus and rabies.

Usage: Rarely used due to labor intensity and relatively low sensitivity.
Function: Best for viruses that don't grow well in culture; requires high titer (10^6 to 10^7 particles/mL).
- Immunoelectron microscopy enhances detection by forming antibody-bound aggregates.
Applications: Useful for detecting gastroenteritis viruses (like astroviruses) and encephalitis viruses (such as HSV, measles virus, JC polyomavirus) that are undetectable through cell culture.

Development: High-quality viral antibody reagents led to tests like fluorescent antibodies, enzyme immunoassays, latex agglutination, and immunoperoxidase tests.
Direct Immunofluorescence: Uses labeled antiviral antibodies (usually fluorescein isothiocyanate) applied directly to suspected specimens.
- Example: Direct immunofluorescence testing for H1N1 influenza A.
Indirect Immunofluorescence: A two-step process with an unlabeled antibody followed by a labeled one, increasing sensitivity through signal amplification.
Staining Patterns: Interpretation based on staining intensity (e.g., negative to brilliant apple-green fluorescence); false positives may occur.
Screening Pools: Can test for multiple viruses, but may be less sensitive in adult specimens.

Methods: Enzyme-linked immunosorbent assay (ELISA) provides qualitative (positive/negative) and quantitative (titer) results.
Advantages: Sensitive and easy to automate, but has limitations in assessing specimen quality.
Other Techniques: Immunoperoxidase staining and latex agglutination; the former is less common than immunofluorescence.

Description: A BHK cell culture system with a beta-galactosidase gene that indicates viral infection.
Function: HSV infection leads to blue-stained cells; confirms presence of HSV types 1 and 2.

Shift in Testing: Nucleic acid detection techniques have improved virology testing; results can be obtained in 2–6 hours.
Probes: Short DNA segments hybridize with viral DNA/RNA, allowing for detection via fluorescence or color change.
PCR: Amplifies viral DNA, can detect even low amounts via real-time PCR; also applicable for RNA viruses through RT-PCR.

Requirements: Living cells, suitable culture media, and maintenance methods.
Observation: Inoculated cultures are periodically inspected for cytopathic effects (CPE), graded from 1+ to 4+.
Media Types: Growth medium (high serum) and maintenance medium (lower serum) to support cell growth and metabolism.

Efficiency: Allows quicker virus detection through early viral antigens without waiting for CPE, typically identifies viruses within 1-2 days.
Method: Consists of adding a coverslip for cell adherence, low-speed centrifugation, and staining for confirmation.

Detection: CPE recognition leads to identifying viruses, often based on morphology and rapidity of CPE development.
Confirmation: Utilization of fluorescent-labeled antisera and hemadsorption techniques.

Use of Antibodies: IgM can indicate recent infections while IgG remains for life; a significant increase in IgG indicates reinfection or reactivation.
Methods of Detection: Complement fixation (CF), ELISA, indirect immunofluorescence, and Western blotting to identify viral antibodies.